CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Polyethylene Glycol for the Treatment of Constipation in Patients in Acute and Long-Term Care: Cost-Effectiveness and Guidelines

Last updated: July 14, 2015
Project Number: RA0785-000
Product Line: Rapid Response
Report Type: Reference List
Result type: Report

Question

  1. What is the cost-effectiveness of polyethylene glycol for the treatment of constipation in adults in acute or long-term care?
  2. What is the cost-effectiveness of polyethylene glycol for the treatment of constipation in children in acute or long-term care?
  3. What are the evidence-based guidelines regarding the use of polyethylene glycol for the treatment of constipation in adults in acute or long-term care?
  4. What are the evidence-based guidelines regarding the use of polyethylene glycol for the treatment of constipation in children in acute or long-term care?

Key Message

One economic evaluation was identified regarding the cost-effectiveness of polyethylene glycol for the treatment of constipation in children. One evidence-based guideline was identified regarding the use of polyethylene glycol for the treatment of constipation in children.